Price Chopper has announced that its pharmacies are now carrying the flu vaccine and Price Chopper’s pharmacists can administer it — with no appointment necessary — for anyone over the age of 19 years.
Sanofi Pasteur announced that the Food and Drug Administration approved the use of Menactra [meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine] as a booster vaccination against meningococcal disease in people ages 15 years through 55 years.
Award-winning actress Judith Light — known for TV’s "Who’s the Boss?," "Dallas" and "Ugly Betty" — is joining the National Council on Aging to raise awareness about influenza this season, NCOA announced Monday.
In recognition of the increased risks that seniors have of developing health complications from the flu, pneumonia, shingles and other illnesses, CVS/pharmacy and MinuteClinic have declared September to be Senior Vaccination Month and will be working to raise awareness about the importance of vaccinations for their senior patients.
Walgreens on Wednesday announced a tetanus, diphtheria, pertussis (Tdap) vaccination voucher program, in collaboration with the Alaska Department of Health and Social Services, to help protect against pertussis (whooping cough).
PharmaJet, the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL, the maker of Afluria (influenza vaccine) on Tuesday announced the Food and Drug Administration has approved the PharmaJet Stratis 0.5mL Needle-Free Jet Injector for delivery of Afluria in individuals ages 18 years to 64 years.
Bartell Drugs on Monday announced the launch of a seasonal flu vaccination program, which offers in-store vaccinations at 63 Bartell Drug locations, as well as an off-site flu clinic program that serves area businesses and retirement communities.
High-dose influenza vaccine is 24% more effective than the standard-dose vaccine in protecting persons ages 65 and older against influenza illness and its complications, according to a Vanderbilt-led study published Wednesday in the New England Journal of Medicine.
GSK has begun shipping Fluarix Quadrivalent (influenza vaccine) doses to U.S. healthcare providers, the company annouced. This marks the first shipment of GSK's U.S. flu vaccine supply for the flu season, which follows licensing and lot-release approval from the Food and Drug Administration's Center for Biologics Evaluation and Research.